Abdominal Aortic Aneurysm Screening Before Coronary Artery Bypass Surgery

February 11, 2023 updated by: Kamile Özeren Topçu, Basaksehir Cam & Sakura Şehir Hospital

Association of SYNTAX Score With Abdominal Aortic Aneurysm in Patients Undergoing Coronary Artery Bypass Graft Surgery: Who Should be Screened?

Coronary artery disease (CAD) and abdominal aortic aneurysm (AAA) are two separate entities with common risk factors such as hypertension, advanced age, male sex. Atherosclerosis plays an important role in the etiology of both diseases. It has been reported that AAA is more prevalent in patients undergoing coronary artery bypass grafting (CABG). Despite all the evidence, current guidelines do not recommend routine screening for AAA before CABG. Syntax score shows anatomical significance of CAD and is associated with the degree of atherosclerotic load. The investigators aim to investigate if there were any differences regarding AAA prevalence in high-SYNTAX patients versus intermediate/low-SYNTAX patients.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

170

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Recruiting
        • Basaksehir Cam ve Sakura City Hospital
        • Contact:
          • Kamile Ozeren Topcu, MD
          • Phone Number: 902169096000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Consecutive adult patients undergoing elective CABG in the Department of Cardiovascular Surgery in Basaksehir Cam Sakura City Hospital

Description

Inclusion Criteria:

  • Undergoing coronary artery bypass graft surgery
  • Age >18 years

Exclusion Criteria:

  • Age <18 years
  • Pregnancy
  • Breastfeeding
  • Emergency surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
High-SYNTAX score patients
Diagnostic test: Abdominal aortic Duplex ultrasound
All patients will undergo bedside Duplex ultrasound in order to measure infrarenal abdominal aortic diameter.
Intermediate/low-SYNTAX score patients
Diagnostic test: Abdominal aortic Duplex ultrasound
All patients will undergo bedside Duplex ultrasound in order to measure infrarenal abdominal aortic diameter.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infrarenal abdominal aortic diameter
Time Frame: Baseline
Infrarenal abdominal aortic diameter measured by bedside Duplex ultrasound by the principal investigator, Dr. Ozeren-Topcu
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Basaksehir Cam & Sakura Şehir Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 15, 2022

Primary Completion (ANTICIPATED)

August 15, 2023

Study Completion (ANTICIPATED)

August 30, 2023

Study Registration Dates

First Submitted

July 2, 2022

First Submitted That Met QC Criteria

July 6, 2022

First Posted (ACTUAL)

July 8, 2022

Study Record Updates

Last Update Posted (ESTIMATE)

February 14, 2023

Last Update Submitted That Met QC Criteria

February 11, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KAEK/2022.02.43

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Abdominal aortic Duplex ultrasound

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe